Plexin A2 Knockdown Enhances Apoptosis in Chemotherapy Treated Melanoma Cells [0.03%]
plexin a2敲低增强化疗处理的黑色素瘤细胞凋亡
Nadezhda Palkina,Aleksandra Esimbekova,Ekaterina Lapkina et al.
Nadezhda Palkina et al.
Background: Cancer cells are characterized by the ability to exit reversibly from the cell cycle to resist an unfavorable environment. This study elucidates alterations in adhesion molecule expression in melanoma cells ac...
Circ72688 Drives Breast Cancer Invasion and Metastasis via the miR-654-5p/ORAI2 Axis [0.03%]
Circular RNA Circ72688通过miR-654-5P/ORAI2轴促进乳腺癌侵袭和转移
Haojie Yang,Zicong Tan,Zihao Liu et al.
Haojie Yang et al.
Background: Circular RNAs (circRNAs) play a crucial role in the progression of malignant tumors such as breast cancer. Methods: A circR...
Glutathione Peroxidases 1 and 3 Immunoscores in Clear Cell Renal Cell Carcinoma: New Insights from a Case-Series Study [0.03%]
肾细胞癌中的谷胱甘肽过氧化物酶1和3的免疫评分：来自病例系列研究的新见解
Dimitra P Vageli,Panagiotis G Doukas,Nikolaos Papageorgiou et al.
Dimitra P Vageli et al.
Background: Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, with a poor prognosis in advanced stages. Although histological tumor grading is an established prognostic parameter, it often fai...
Elucidating the Potential Targets and Mechanisms of Bisphenol A-Induced Prostate Cancer Based on Network Toxicology and Molecular Docking Analyses [0.03%]
基于网络毒理学和分子对接分析阐明双酚A诱导前列腺癌的潜在靶点及机制研究
Ashuai Du,Dianbin Guo,Dongbo Yuan et al.
Ashuai Du et al.
Background: Bisphenol A (BPA) is a widely used industrial chemical and endocrine-disrupting compound, and accumulating evidence suggests that it may contribute to prostate cancer progression; however, the underlying molec...
Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival [0.03%]
贝伐单抗与紫杉醇治疗晚期激素受体阳性乳腺癌：最佳总生存率的多因素维度减少方法论分析
Luigi Coltelli,Paola Orlandi,Chiara Finale et al.
Luigi Coltelli et al.
Background: The treatment of advanced hormone receptor-positive (HR+) breast cancer has seen relevant changes in last years. However, bevacizumab remains an option when combined with paclitaxel, but no certified pharmacog...
Retraction: MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1 [0.03%]
撤稿：MicroRNA-510通过直接靶向SRC激酶信号抑制蛋白1在非小细胞肺癌中发挥致癌作用
Oncology Research Editorial Office
Oncology Research Editorial Office
[This retracts the article DOI: 10.3727/096504018X15451308507747.]. © 2026 The Author. Published by Tech Science Press.
Melatonin in Integrative Oncology: Biological Mechanisms, Therapeutic Evidence and Implementation Strategies [0.03%]
褪黑素与整合肿瘤学：生物学机制、治疗证据及实施策略
Jarosław Nuszkiewicz,Joanna Wróblewska,Marek Jóźwiak et al.
Jarosław Nuszkiewicz et al.
Melatonin, an endogenous indoleamine primarily synthesized in the pineal gland, has emerged as a promising adjunctive agent within integrative oncology due to its pleiotropic biological actions. Beyond its well-known chronobiological functi...
In Vivo CAR-T Therapy for Cancer Treatment: Mechanisms, Technological Advances, and Clinical Translation [0.03%]
体内CAR-T癌症治疗疗法：机制、技术进展与临床转化
Lu Hao,Jiao Lu,Jisu Xue
Lu Hao
In vivo Chimeric Antigen Receptor (CAR)-T cell therapy reprograms a patient's own T cells directly inside the body, bypassing the complex and costly traditional manufacturing process. This is achieved by systemically delivering viral or non...
Navigating the Labyrinth of Hepatocellular Carcinoma: Leveraging AI/ML for Precision Oncology [0.03%]
肝细胞癌的精准肿瘤学：利用人工智能/机器学习应对迷宫式的治疗挑战
Abdul Manan,Sidra Ilyas
Abdul Manan
Hepatocellular carcinoma (HCC) remains a significant global health challenge, with therapeutic efficacy in advanced stages often limited by underlying liver dysfunction and adaptive resistance. In this review, the evolving landscape of mole...
Targeting SRC/STAT3 Signaling Impairs Cancer Stem Cell Activity by Downregulation of Hexokinase-2 in Radioresistant Triple-Negative Breast Cancer Cells [0.03%]
靶向SRC / STAT3信号通路通过下调己糖激酶-2抑制三阴性乳腺癌放疗抵抗细胞的癌症干细胞活性
Yu-Hao Huang,Yu-Ci Tu,Peng-Ju Chien et al.
Yu-Hao Huang et al.
Background: Triple-negative breast cancer (TNBC) is an aggressive subtype with poor prognosis and resistance to conventional therapies, including radiotherapy. Cancer stem cells (CSCs) drive tumor initiation, metastasis, ...